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Abstract 
Parkinson’s disease is one of the most common degenerative neurological disorders and 
is currently lacking a cure. While physicians have long debated over the best treatment 
for Parkinson’s symptoms, treatments such as oral medication and deep brain stimulation 
have not yet shown to be a permanent solution to the disease. Recently, exercise has 
emerged as a contender in the fight against Parkinson’s and physicians and 
physiotherapists have been investigating the benefits of prescribing exercise programs to 
patients in an effort to slow progression of Parkinson’s symptoms. The following 
presents an analysis of the effects of exercise on Parkinson’s symptoms and whether or 
not the type of exercise prescribed is efficacious in the reduction in symptoms 
experienced by patients. This analysis involves weighing the physical and psychological 
benefits and risks of exercise intervention in individuals with Parkinson’s disease. 
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The Physiology and Psychology of Exercise and Parkinson’s Disease 
 Medicine, like many other aspects of culture, is constantly changing. With these 
advancements come a surge of new ideas as physicians attempt to determine the ideal 
way to care for patients and treat illnesses. Although medication remains the gold 
standard for the treatment of many chronic diseases, many physicians have begun to 
encourage their patients to focus on diet and lifestyle changes as a form of preventive 
medicine. This new lifestyle-centered care approach allows patients to take their health 
into their own hands and experience tangible results as they witness first-hand how 
changes in their diet and lifestyle will affect their health and quality of life. Although the 
benefits of exercise are difficult to dispute, the idea of exercise as medicine has emerged 
fairly recently, and with it comes the opportunity for extensive research on the benefits of 
exercise as a potential treatment for many chronic diseases. 
Overview of Parkinson’s Disease 
 Parkinson’s disease (PD) is a degenerative neurological disorder that affects the 
body’s central nervous system (CNS), generally involving older individuals and, as of 
yet, does not have a cure. Both men and women are at risk of developing PD, however, 
the disease is twice as common among men (Bollinger, Cowan, & LaFontaine, 2012). 
Recent research has shown that certain genes have been linked to PD and that first-degree 
relatives of PD patients are at a higher risk of developing the disease themselves 
(Bollinger et al., 2012). Symptoms of PD are caused by a deficiency in the dopamine-
generating cells of the brain. A chemical crucial to the initiation of movement, dopamine 
is secreted from the substantia nigra of the midbrain and acts indirectly via a process 
called the second messenger system, whereby dopamine binds to receptor proteins 
EXERCISE AND PARKINSON’S 5 
 
embedded in cell membranes, causing these proteins to in turn release chemicals that 
affect intracellular functions (Marieb & Hoehn, 2013). In PD patients, the dopamine-
generating cells of the substantia nigra begin to deteriorate, causing their target cells to 
become overactive (Marieb & Hoehn, 2013). With the death of the brain’s dopamine 
cells resulting in a dopamine deficiency in the body, the movement-initiating parts of the 
brain are not able to function at their former capacity. As dopamine levels continue to 
diminish, Parkinson’s symptoms will worsen in a progressive manner (Heisters, 2011).  
Many Parkinson’s patients are put on medications in order to minimize their 
suffering and increase their ability to take care of themselves. However, these 
medications will usually only mask the symptoms that patients are experiencing, and the 
disease will continue to progress. Eventually, Parkinson’s patients will reach a point in 
their disease progression where they are unable to care for themselves and become 
dependent on either hospice care or a primary caregiver. Quality of life decreases until 
life is no longer enjoyable for the patient due to the severity of symptoms and the 
inability to perform even the simplest tasks of daily living. As with many diseases, early 
intervention is encouraged with Parkinson’s patients. However, due to the relatively slow 
progressive nature of PD, symptoms will not immediately appear to be severe and may be 
dismissed as the effects of aging. The presence of only mild symptoms at disease onset 
can lead to a delay in diagnosis and patients might not receive a correct diagnosis until 
their symptoms have manifested significantly (Bollinger et al., 2012). 
Motor Symptoms of Parkinson’s Disease 
 The most easily identifiable symptoms of Parkinson’s disease are the physical 
symptoms, although they may originally be dismissed as the effects of aging until the 
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disease has progressed further. Four major symptoms are indicative of Parkinson’s 
disease: a resting postural tremor, bradykinesia (slowness of movement), stiffness or 
rigidity of muscles, and decreased reflexes. Secondary symptoms include, but are not 
limited to, dyskinesia (irregular movement patterns due to a loss of voluntary movement 
control) and freezing (a sudden inability to generate movement) (Bollinger et al., 2012). 
These symptoms generally affect aspects of movement such as gait and balance. 
Parkinson’s patients generally experience difficulty walking, as well as difficulty 
performing any quick or precise movements. Due to the progressive nature of PD, 
physical symptoms will only get worse as the patient ages.   
Non-motor Symptoms of Parkinson’s Disease 
 Perhaps more difficult to identify are the non-motor symptoms of PD, as some of 
these symptoms are psychological by nature rather than physical. Symptoms include 
apathy and depression, anxiety and stress, trouble sleeping, and impaired cognitive 
function (Van der Kolk & King, 2013). Like the motor symptoms of PD, non-motor 
symptoms are mild at disease onset with continued progression through the remaining 
stages of life. A survey conducted in the United Kingdom in 2008 showed that the 
severity of non-motor symptoms among PD patients increased with disease progression 
(Breen & Drutyte, 2012). Although the majority of non-motor symptoms do not 
contribute to movement deficiencies, symptoms such as depression and sleep disorders 
can still affect patients physically. In fact, new advancements in a patient-centered 
approach to the treatment and diagnosis of PD have shown that the non-motor symptoms 
of the disease can affect patients just as severely, if not more so, than the motor 
symptoms (Breen & Drutyte, 2012). 
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 Since Parkinson’s disease is an age-related disorder, symptoms of PD are often 
accompanied by other age-related health issues such as high blood pressure, arthritis, and 
cardiovascular disease (Bollinger et al., 2012). These age-related conditions are not 
caused by PD, but the presence of these issues can make the already-uncomfortable life 
of a Parkinson’s patient even worse. 
Progression of Parkinson’s Symptoms 
 In order to ensure a universal assessment method for all PD patients, physicians 
have adopted two separate scales in order to assess a patient’s symptoms. The Unified 
Parkinson’s Disease Rating Scale (UPDRS) is used to rate the severity of a patient’s 
symptoms, whereas the Hoehn and Yahr scale is used to rate the progression of a 
patient’s symptoms. Although there had been few previous attempts to correlate UPDRS 
values with Hoehn and Yahr values, a 2012 study revealed a significant correlation 
between UPDRS and Hoehn and Yahr stage, going so far as to say that one could infer a 
patient’s Hoehn and Yahr stage based on the individual’s UPDRS rating (Tsanas, Little, 
McSharry, Scanlon, & Papapetropoulos, 2012). In other words, a physician should 
generally be able to determine how far a patient’s disease has progressed depending on 
the severity of the patient’s symptoms. 
Hoehn & Yahr stage 
0: No visible symptoms of Parkinson’s disease 
1: Parkinson’s disease symptoms just on one side of the body 
2: Parkinson’s disease symptoms on both sides of the body and 
minimal difficulty moving 
3: Parkinson’s disease symptoms on both sides of the body and 
minimal difficulty walking 
4: Parkinson’s disease symptoms on both sides of the body and 
moderate difficulty walking 
5: Parkinson’s disease symptoms on both sides of the body and 
unable to walk 
 
 
Figure 1. Hoehn and Yahr stages as a general 
guideline for the progression of PD. (Tran, 2015) 
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Treatment of Parkinson’s Disease 
Prescription Medication 
 Recent studies have seen various opinions on the best method for treating 
Parkinson’s disease. Treatment methods vary greatly, from oral medication to surgical 
procedures and, recently, the introduction of the idea of exercise as a way of managing 
the symptoms of PD. Levodopa has been one of the medications of choice for many 
physicians attempting to slow the progression of PD in their patients. An intermediate in 
the process of dopamine formation, orally ingested levodopa makes its way to the brain 
where it assists in the production of dopamine in an effort to correct dopamine 
deficiencies caused by PD. In some cases, physicians may prescribe a pump instead of 
oral medication in order to better control a patient’s doses and to adjust a continuous flow 
of medication as symptoms fluctuate throughout the day. However, although levodopa 
functions incredibly well for most patients at the beginning of prescription, it has been 
shown to cause motor complications later in life. Additionally, treatment with levodopa 
has been shown to cause adverse side effects, including nausea, in some patients, which 
physicians have attempted to counter by prescribing a combination of levodopa and 
carbidopa, a drug which has come to be referred to as the gold standard of PD treatment 
(Rascol, 2013). Unfortunately, while levodopa has been shown to slow progression of PD 
in the short term, it appears to function only so long as patients continue to take the 
medication and long term effects of levodopa on PD remain uncertain (LeWitt, 2008).  
 
 
EXERCISE AND PARKINSON’S 9 
 
Deep Brain Stimulation in Addition to or as an Alternative to Prescription 
Medication 
Researchers are still in search of a PD treatment that continues to work long term. 
Recently, Deep Brain Stimulation (DBS) has emerged as a contender to oral medication. 
The surgical process involves the implantation of a small electrode in the brain that can 
then be turned on or off depending on the patient’s needs. The device, which essentially 
functions as a pacemaker in the brain, is responsible for decreasing Parkinson’s 
symptoms via stimulation, providing patients with an alternative to oral medication. 
While some physicians still prescribe oral medication to DBS patients, the dosages are 
significantly reduced. The DBS treatment has been shown to improve motor function, 
speech, and occasionally mood and perceived quality of life of the patient (Benabid, 
2003). However, as with any surgery, there are multiple risks associated with the DBS 
process and in the past it has been seen as a last resort treatment. Additionally, only a 
small percentage of PD patients qualify for DBS because of the high risks associated with 
the procedure. According to Limousin and Martinez-Torres (2008), patients who 
experience mental disorders such as dementia or psychosis run the risk of their conditions 
worsening following the DBS procedure. This accelerated deterioration is likely due to a 
combination of the stimulation and a sudden reduction in oral medication doses 
(Limousin & Martinez-Torres, 2008). Furthermore, certain patients, particularly those 
who exhibit freezing and balance problems, reported inconsistent results in their 
symptoms after receiving the surgery (Limousin & Martinez-Torres, 2008). Generally, 
the DBS procedure is not performed until 11-13 years after the onset and diagnosis of 
PD, although recently physicians have discovered that patients could potentially benefit 
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from having the surgery earlier (Godden, 2014). The fact remains, however, that neither 
the levodopa-carbidopa combination nor DBS is a permanent solution to Parkinson’s 
disease. While various treatments are available, the disease is still lacking a cure, and 
while researchers have by no means stopped searching for a cure, much of the focus in 
PD treatment has shifted to attempts to alleviate symptoms, slow disease progression, and 
help maintain patient quality of life for as long as possible. 
Exercise Therapy as a Treatment for Parkinson’s Disease 
 In light of the ever-increasing popularity of diet and lifestyle changes as a 
treatment for a variety of problems, exercise has emerged as a potential solution to the 
decreased motor function and quality of life associated with aging and, more specifically, 
Parkinson’s disease. Opinions differ on how effective this kind of treatment is, as the 
effectiveness of treatment depends largely on the specific patients treated, as well as the 
type, intensity, and duration of exercise prescribed. A study done by Dibble, Hale, 
Marcus, Gerber, and LaStayo (2009) showed a decrease in bradykinesia (slowness of 
movement) and an improved quality of life in patients ages 40-85 suffering from mild to 
moderate PD (Hoehn & Yahr stages 1-3) who participated in a high intensity resistance 
training program. Previous exercise interventions among Parkinson’s patients have 
typically not highlighted resistance training as an important part of the exercise program. 
However, resistance training results in significant increases in muscular strength and 
endurance, and increases in muscular strength and endurance are especially important for 
those suffering from movement disorders (Pescatello, 2014). The key to using exercise 
therapy as a treatment for PD, however, is to use a well-rounded exercise program that 
focuses on maintaining range of motion, strength, balance, and movement speed, and this 
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cannot be accomplished solely through resistance training. Generally, the best exercises 
to help slow disease progression in PD patients are those that emphasize balance, 
movement initiation, and movement control (Pescatello, 2014). The LSVT (Lee 
Silverman Voice Treatment) programs for PD patients have been designed for this 
purpose. Originally the LSVT Loud program was developed as a speech therapy program 
for PD patients, with the LSVT Big program added in an effort to treat movement 
deficiencies in addition to speech deficiencies. The goal of the LSVT Big program is to 
emphasize amplitude of movement instead of speed. Additionally, patients are coached 
on movement precision and accuracy (Fox, Ebersbach, Ramig, & Sapir, 2012). 
Conversely, a training program that focuses solely on aerobic exercise and cardiovascular 
endurance would not greatly benefit PD patients. Although individuals with Parkinson’s 
can improve their cardiorespiratory endurance just like anyone else (Bergen et al., 2002), 
this kind of exercise does not do much to improve balance and movement initiation. 
Cardiorespiratory endurance is still an extremely important component of physical 
fitness, but the prescription of aerobic exercise does not target the movement deficiencies 
caused by Parkinson’s disease. 
 The American College of Sports Medicine (ACSM) recommends an exercise 
prescription for PD patients that places focus on improving gait, transfers, balance, joint 
mobility, and muscle power (Pescatello, 2014). The ideal exercise program should 
address all components of physical fitness (muscular strength, muscular endurance, 
cardiorespiratory endurance, and flexibility) in addition to addressing gross functional 
movement and more precise fine motor skills. Naturally, a PD patient’s exercise program 
needs to be under constant revision, as a combination of disease progression and the 
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effects of aging may prevent patients from performing exercises they were once capable 
of. While it is certainly possible for PD patients to show improvement in the various 
areas of physical fitness, a more realistic goal is maintenance of current physical fitness 
levels for as long as possible, and focus on delaying the onset of symptoms. Due to the 
progressive nature of PD, the ACSM emphasizes the importance of early intervention 
when prescribing an exercise program to PD patients, as a patient’s ability to participate 
in physical activity will decrease the longer the disease is allowed to progress. 
Effects of Various Exercise Interventions on Parkinson’s Disease 
Parkinson’s Disease and Aerobic Exercise 
 A study published in 2002 analyzed the effects of a sixteen week aerobic exercise 
intervention on both aerobic capacity and movement initiation in PD patients (Bergen et 
al., 2002.) According to the researchers:  
[A]erobic exercise has been shown to play a significant role in the prevention and 
reversibility of chronic diseases such as coronary heart disease, diabetes, and 
osteoporosis; however, very little conclusive evidence is available concerning the 
effects of aerobic exercise on PD. (Bergen et al., 2002, p. 161)  
For the purposes of the study, aerobic capacity was defined as an individual’s peak VO2, 
and movement initiation (MI) was defined as the amount of time required for elbow 
flexion and extension. Eight participants aged 47 to 74, all of whom were in Hoehn and 
Yahr stage 2, were assigned to either a control group or an intervention group. After 
undergoing a pre-test for peak VO2 and MI times, the control group was instructed to 
continue on with their regular exercise routine, while the intervention group was 
prescribed a sixteen week aerobic exercise intervention that consisted of stretching 
EXERCISE AND PARKINSON’S 13 
 
exercises and a combination of cycling and treadmill walking with speed and resistance 
adjusted to keep participants in their target heart rate (THR) zone at all times. Following 
the sixteen week period, all participants completed a post-test to assess changes in their 
MI and peak VO2. Participants in the intervention group showed remarkable 
improvement, improving their peak VO2 scores by an average of 5.0 mL/kg/min in 
addition to improving their MI time by approximately 120 ms. Additionally, following 
the sixteen week intervention, mean MI times for the intervention group were closer to 
those of healthy non-PD individuals than to members of the PD control group.  
Results of this study are important, as they show that PD patients have the ability 
to improve their movement initiation with exercise, showing that PD symptoms, despite 
their progressive nature, are at least somewhat reversible. Additionally, this study shows 
that MI can be improved solely through aerobic exercise in conjunction with stretching, 
with no additional resistance training or emphasis on gross motor skills. However, 
although improvement in MI was shown following the sixteen week intervention, there is 
no indication of whether or not these gains were maintained when exercise ceased, or 
only lasted so long as the individual continued with the aerobic exercise program. 
Improvement in peak VO2 among participants in the intervention group, although 
significant, is to be expected, and this trend is not limited to PD patients as aerobic 
exercise has been shown to increase cardiorespiratory fitness in healthy as well as 
diseased individuals. An increase in peak VO2, although beneficial to the subject, likely 
has no effect on the motor symptoms of PD. It is more likely that the significant increases 
in VO2 are present to indicate that the aerobic intervention worked for its intended 
purpose (increasing the cardiorespiratory endurance of the patients who participated in 
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the program). Furthermore, all participants studied were in Hoehn and Yahr stage 2, 
indicating that they were experiencing symptoms but did not yet have any difficulty 
walking. While there is no doubt that the aerobic exercise intervention was beneficial for 
these patients, aerobic exercise may not be the ideal intervention for individuals whose 
disease has progressed further (Hoehn and Yahr stages 3-5).  
 An additional criticism of this study is the fact that so few participants were used; 
only four in the control group and four in the intervention group. This is likely due to the 
difficulty in finding a large enough sample of PD patients who are at the same stage in 
their disease progression and are capable of completing the required sixteen weeks of 
exercise without having to drop out of the study. However, despite the fact that patients 
in the intervention group showed a significant increase in VO2max and movement 
initiation time, one must wonder how comparable the results can possibly be to the PD 
population as a whole if only four participants were used. It is possible that these four 
patients were special cases and that an aerobic exercise intervention would not actually 
improve MI times among the majority of Parkinson’s patients. Although the results found 
were significant, a larger sample size would be needed before the results of this study 
could be seen as meaningful. 
 A different study conducted in 2006 used 22 PD patients in Hoehn and Yahr 
stages 2-3 and focused on an exercise intervention that combined aerobic training with 
Qigong, a Chinese physiotherapy method that focuses on stretching and breathing 
exercises and has been shown to improve self-reported quality of life in individuals with 
chronic conditions (Burini et al., 2006). This study, like the study done by Bergen et al., 
showed that Parkinson’s patients can achieve cardiorespiratory gains through aerobic 
EXERCISE AND PARKINSON’S 15 
 
exercise just like healthy individuals. However, the Burini et al. study was unable to find 
any significant impact of aerobic exercise on PD symptoms, nor was there a significant 
difference in perceived quality of life in patients following the intervention. 
Parkinson’s Disease and Resistance Training 
 In 2009, Dibble et al. published one of the first studies to look at the impact of 
high intensity resistance training on Parkinson’s symptoms. Twenty participants ages 40-
85 in Hoehn and Yahr stages 1-3 were recruited to take part in a twelve week program 
and were randomly assigned to either a control group or an intervention group. In this 
case, both groups followed an exercise program and the variable was the addition of high 
intensity resistance training for the participants in the intervention group. Participants 
were pre-tested for force generation (via isometric contraction of the quadriceps muscle), 
bradykinesia during gait (via a 10m walk and timed up and go tests) and were asked to 
indicate their perceived quality of life through the Parkinson’s Disease Questionnaire 
(Dibble et al., 2009). Following the twelve week intervention, participants were post-
tested on the same criteria. 
 Participants in both the control and experimental groups showed strength gains 
following the intervention. Most interesting, however, were the changes shown in 
bradykinesia. While the control group showed a decrease in gait speed over the twelve 
week period, the intervention group that completed high intensity resistance training in 
addition to the standard exercise protocol showed a 12% increase in walking speed on the 
timed 10m walk. Additionally, participants in the intervention group achieved faster 
times on their timed up and go post-test, while participants in the control group showed 
virtually no change in times from pre-test to post-test.  
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 Although ASCM exercise prescription guidelines generally do not recommend 
high intensity resistance training with frail, elderly, or movement-impaired individuals, 
this study provides interesting insight into the ways that a resistance training program 
could potentially be beneficial for certain Parkinson’s patients. However, the benefits of 
such a program do not come without risks, and it is imperative that patients engage in 
resistance training in a safe and controlled environment in addition to obtaining clearance 
from a physician prior to beginning exercise. Furthermore, such a program, although 
beneficial for patients in early stages of PD, would not be recommended for patients with 
severe movement deficiencies such as those in Hoehn and Yahr stages 4 and 5. 
Parkinson’s Disease and Assisted Cycling 
 In keeping with the idea of using intensity as a variable in an exercise program for 
PD patients, a study published in 2012 looked at altering an individual’s cycling cadence 
on a stationary bicycle, enabling patients to achieve a faster pedaling rate than they would 
normally be capable of on their own (Ridgel, Peacok, Fickes, & Kim, 2012). A previous 
study done by Ridgel, Vitek, and Alberts (2008) looked at the impact of forced versus 
voluntary exercise by assigning ten patients to one of two groups: a control group where 
they were instructed to cycle on their own, or an experimental group where patients were 
placed on a tandem bike with a trainer and were forced to pedal at the same speed as the 
trainer (a cadence faster than their own voluntary speed) through a system that linked the 
pedals of the participant to the pedals of the trainer. The results of this study showed a 
35% motor function increase in patients placed in the forced exercise group, compared to 
no increase in motor function in the group that was allowed to determine their own 
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cycling cadence. Patients from both groups showed an improvement in their 
cardiorespiratory endurance. 
 The 2012 study utilized an active assisted cycling system that functioned similar 
to the tandem bicycle, but with the absence of a trainer, in an effort to identify whether or 
not high intensity assisted cycling could be used as an exercise intervention for PD 
patients in the home and to determine the possibility of active assisted cycling as an 
alternative to the tandem cycling used in the 2008 study. The modified assisted cycling 
system consisted of a stationary bicycle, which was computerized in order to allow 
patients to select a set cadence. Patients were instructed to attempt to pedal faster than the 
set cadence, but in the event that they were unable to do so, the computerized system took 
over and began to move their legs for them, ensuring that all patients maintained a speed 
of at least 75 revolutions per minute (rpm) throughout their workout. Patients were tested 
in both ON and OFF medication states in order to determine whether or not a single 
session of active assisted cycling would have an effect on bradykinesia and resting 
postural tremor regardless of whether or not the individual was relying on medication. 
Ten participants in the study aged 54-75 (Hoehn & Yahr stages 1-3) were tested for 
bradykinesia and resting postural tremor both before and after completing a single 30 
minute cycling session. 
 The post-test revealed an immediate change in the bradykinesia and resting 
postural tremor of patients following their cycling session. Furthermore, despite the fact 
that the cycling intervention focused solely on the legs, patients showed improvement in 
bradykinesia and resting postural tremor of the hands, indicating that the cycling 
intervention had an impact on the entire central nervous system instead of being strictly 
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limited to the parts of the body that were stressed in the exercise intervention. These 
findings coincide with the findings from the Bergen et al. (2002) study, where aerobic 
training improved movement initiation time despite the fact that movement initiation was 
never trained directly in the exercise intervention. Additionally, Ridgel et al. (2012) 
found that the cycling session lessened disease symptoms by affecting the same areas of 
the brain that are usually affected by Parkinson’s medication. The fact that acute bouts of 
active assisted cycling affect the body in similar ways as medication is groundbreaking, 
as it presents exercise as a potential alternative for medication in the early stages of PD. 
In addition, participants showed improvement after only a single exposure to the exercise 
intervention, suggesting that a long and complicated exercise regimen is not required in 
order for PD patients to begin to experience alleviation of symptoms. 
Taking a Biopsychosocial Approach to Parkinson’s Disease 
 While treating the motor symptoms of PD deals purely with the body’s 
physiology, non-motor symptoms present an additional host of complications. Not only 
do patients experience dizziness, incontinence, difficulty speaking and swallowing, and 
trouble with sleeping, those who suffer from PD can also develop severe anxiety and 
depression and may suffer from pain and hallucinations. Additionally, approximately one 
third of PD patients will develop dementia, usually within 12 years of being diagnosed 
with Parkinson’s (Heisters, 2011). Although it can be easy to overlook the non-motor 
symptoms of PD in favor of treating the motor symptoms, new developments in medicine 
have begun to encourage physicians to focus on the biopsychosocial approach to treating 
patients; an approach born out of the criticism that physicians place too heavy of a focus 
on the biological components of a patient’s disease, sometimes to the point of neglecting 
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the patient’s psychological and social well-being. The biopsychosocial model of health 
seeks to correct this issue in health care by mandating that physicians take a more open 
and well-rounded approach to illnesses, focusing on the way that the illness affects the 
patient as a person and prioritizing the patient’s overall quality of life over the importance 
of the treatment of individual symptoms (Zittel, Lawrence, & Wodarski, 2002). The idea 
behind taking a biopsychosocial approach to care is that patients will be far more open to 
various treatment options if they already feel safe and content about their overall quality 
of life. In contrast, medications will not appear to be as effective in the cases of patients 
whose disease causes them to experience severe bouts of anxiety and depression, as 
physicians design the majority of PD treatments with a focus on alleviating motor 
symptoms and generally do not have the psychological symptoms of the disease in mind. 
Exercise and Depression 
 Major depressive disorder (MDD) affects an estimated 16% of Americans (Aan 
het Rot, Collins, & Fitterling, 2009), and, along with anxiety, is one of the major 
psychological symptoms that affects individuals diagnosed with PD (Breen & Drutyte, 
2012). In fact, a Finnish study published in 2000 showed that the individuals who scored 
the highest for depression were those who suffered from a chronic disease or injury 
(Hassmén, Koivula, & Uutela, 2000). While these findings are not unexpected, as it 
makes sense that those who suffer from chronic illness will experience the feelings of 
unease and helplessness that often lead to depression. This adds additional complexity to 
the treatment of chronic diseases such as PD, as depression is a disease in itself, albeit a 
mental disease instead of a physical one, and therefore must be treated as such.  
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 The Hassmén et al. (2000) study attempted to determine the effects of exercise on 
depression by surveying participants on their exercise habits and then scoring them on the 
Beck Depression Inventory (BDI), a 21 question assessment that ranks individuals on 
various components of MDD before giving them a score on the depression scale. 
Analysis of the survey results showed that those who indicated that they exercised 
infrequently or not at all scored higher on the depression scale than those who indicated 
exercising two to three times a week. Interestingly, results also showed that individuals 
who reported exercising most often (almost every day of the week) also scored higher on 
the depression scale than the individuals who exercised two to three times per week. 
These findings indicate that a moderate exercise program of two to four days per week 
would likely be ideal in order to minimize the chances of a high score on the depression 
scale. Additionally, these findings coincide with findings about the neurobiology of 
exercise, including the phenomenon generally referred to as runner’s high; the state of 
elation and decreased sensitivity to pain that is often experienced by athletes following a 
long run. This is due to the release of endorphins; a type of opioid that has been shown to 
regulate mood and induce the euphoria seen in many runners. However, it should be 
noted that the runner’s high phenomenon does not seem to affect all runners, nor does it 
appear to affect runners with much consistency (Aan het Rot et al., 2009). Another 
hypothesis focuses on the levels of serotonin and norepinephrine, both neurotransmitters 
that have been linked to depressive effects when deficient in the body. Studies have 
shown that exercise increases the levels of tryptophan, the amino acid from which 
serotonin is derived, in addition to decreasing levels of various other amino acids that 
compete with tryptophan in the brain. This increase in serotonin is similar to the way that 
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many antidepressant medications function (Aan het Rot et al., 2009), presenting a link 
between the psychological benefits of exercise and the body’s response to antidepressant 
medication and showing that exercise could potentially be used as an antidepressant. 
 The path towards alleviating symptoms of depression is, however, infinitely more 
complicated than simply instructing patients to exercise. According to the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5), symptoms of MDD include “the 
presence of sad, empty, or irritable mood, accompanied by somatic and cognitive changes 
that significantly affect the individual’s capacity to function” (American Psychiatric 
Association, 2013, p.155). Along with these symptoms comes a severe lack of 
motivation; those who suffer from depression lack the energy to do the things they enjoy 
and the excitement that once accompanied their favorite activities. In addition, depression 
affects the physiology of patients so that they feel too tired, too sick, or simply less alive 
(Aan het Rot et al., 2009). One of the major reasons that individuals choose not to 
exercise is lack of motivation, whether intrinsic or extrinsic, and individuals who suffer 
from depression and by proxy a severe lack of motivation, are therefore even less likely 
to begin an exercise program in comparison to the average individual. Additionally, 
today’s society is, unfortunately, one of instant gratification, meaning that individuals are 
unlikely to engage in a behavior that does not provide immediate benefits for them. 
Although acute bouts of exercise have been shown to decrease depressive symptoms in 
individuals (North, McCullagh, & Tran, 1990), the long term gains of chronic exercise 
will always be greater and more noticeable than the gains from a single bout of acute 
exercise. Unfortunately, patients who begin an exercise program and do not see 
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immediate gains may write off the benefits of exercise before they have a chance to 
notice any physical or psychological improvements. 
 An additional complication, in the case of PD patients, is that they may have the 
desire to exercise but not the ability. While individuals still in the early stages of the 
disease are capable of walking, running, cycling, and even resistance training, patients 
who have progressed to Hoehn and Yahr stages 4 and 5 may be physically incapable of 
participating in exercise for prolonged periods of time. Although exercise intervention in 
the early stages of PD could potentially serve to delay the onset of depressive symptoms, 
the knowledge that exercise affects the brain in a manner similar to that of medication 
shows that exercise interventions are by no means a cure, simply another way of 
alleviating symptoms. 
Social Support 
 The social component of chronic disease is often overlooked, although it has an 
arguably greater impact on a patient’s life than anything else. Those who suffer from 
chronic diseases are often bed-ridden, in and out of the hospital, or in hospice care, 
severely impacting their ability for social interaction. However, like all people, these 
patients still crave relationships and human interaction. The unfortunate truth is that 
many PD patients seem to lack the level of social support that they need, and instead live 
their lives in various stages of isolation. A patient’s lack of social support could stem 
from a variety of reasons. Since PD primarily affects the elderly, especially in its late 
stages, some patients lack a social support system due to already having lost many of 
their loved ones. Alternatively, friends and family members of those who suffer from PD 
may become intimidated by the amount of time and effort involved in caring for someone 
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with a chronic disease and come to view the individual as a burden, electing to place the 
patient in a hospice or some other form of long-term care. Unfortunately, situations in 
which PD patients are removed from their support network are far from ideal, and could 
potentially cause the individual’s anxiety and depression to worsen (Adams, Sanders, & 
Auth, 2004). 
 With the rise in popularity of the biopsychosocial model of medicine has come an 
increase in the integration of social care into the treatment of PD. Hospitals, hospices, 
retirement homes, and physiotherapy clinics offer group exercise classes such as cycling, 
chair exercises, and dance classes. Additionally, organizations such as the Parkinson’s 
Society Canada and the American Parkinson’s Disease Association have been making an 
effort to provide patients and their caregivers with education about their disease, their 
treatment options, and ways to get involved with groups that offer social support. For PD 
patients, these groups are the best of both worlds, as they provide individuals with the 
opportunity to simultaneously exercise and socialize; opportunities that are more difficult 
to come by when living with a chronic disease. Additionally, these groups can serve to 
provide accountability for individuals who may not be motivated to exercise or socialize 
if they did not have others counting on them. Taking an activity like exercise that may 
seem daunting, especially to patients who may be suffering from depression and lack 
energy and motivation, and turning it into a social activity can make it seem like less of a 
chore and more something that the patient favorably anticipates. The focus of the 
biopsychosocial model of care is on the patient as a whole, which means making every 
effort to maximize the patient’s quality of life throughout their treatment process. 
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Parkinson’s Treatment and Christianity 
 Perhaps the biggest controversy in the Christian medical world is that of quality 
of life versus quantity of life. In other words, is it better to prolong a patient’s life through 
whatever means necessary, occasionally with disregard to the patient’s wishes? Or is it 
better to make the patient feel comfortable and safe in the midst of their disease, even if it 
means foregoing a treatment that could potentially save an individual’s life? Christians in 
the medical field are often faced with this dilemma when asked to make a choice that 
could mean the difference between a patient’s life and death. In a way, the Christian 
worldview aligns with the biopsychosocial model of medicine, emphasizing treatment of 
the patient as an individual instead of treating them as if they are their disease. It is 
important to remember that God is not as much concerned with the amount of time 
people spend on this earth as he concerned with what individuals do with the life that He 
has given to them, and Christian physicians should keep this in mind when treating 
patients who suffer from chronic diseases such as PD. 
 Exercise intervention in patients suffering from Parkinson’s disease has the 
potential to delay the progression of a patient’s symptoms and improve motor function in 
patients with severe movement deficiency, enabling individuals to more easily 
accomplish activities of daily living. In addition to its physical benefits, exercise has been 
shown to have a positive effect on individuals suffering from anxiety and depression, and 
an increase on an individual’s perceived quality of life. Furthermore, exercise can be used 
as a means of socialization, providing patients with much needed support and interaction. 
In light of the innumerable benefits of participation in physical activity by patients living 
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with chronic disease, it can be concluded that an exercise intervention program is a 
valuable addition to the treatment of patients suffering from Parkinson’s disease. 
The Future of Parkinson’s Disease 
 Despite the fact that medicine has progressed by leaps and bounds and is far more 
advanced than it was only a decade ago, many chronic progressive diseases like 
Parkinson’s are still lacking a cure, and while time and energy should certainly be spent 
searching for a cure, it is of equal importance to provide treatment for those who are 
currently suffering from PD. Additionally, early intervention is of utmost importance 
when dealing with a progressive disease. Although it has been shown that it is possible 
for PD patients to gain back some of the motor function they have lost with the help of 
exercise, motor function will become more and more difficult to regain the further the 
disease is allowed to progress without intervention. 
 Since PD is such a highly individual disease, one patient’s symptoms will not 
necessarily progress in the same manner as another patient’s, nor will the treatment used 
for a certain patient necessarily be the best option for another. Because of this, physicians 
need to take care to know their patient in order to prescribe the best treatment in order to 
maximize quality of life. 
 Although oral medication and DBS certainly function to alleviate PD symptoms 
and improve the patient’s quality of life, there is an argument to be made for exercise 
intervention as an initial treatment before resorting to prescription medication and 
surgeries. Since exercise can help PD patients to regain motor function, it stands to 
reason that exercise could also act as a preventive measure against the loss of motor 
function. The longer that patients can delay the onset of disease symptoms by exercising, 
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the longer they can put off becoming dependent on medication or DBS to alleviate their 
symptoms.  
 The unfortunate truth of PD is that the symptoms are inevitable, and they will 
invariably get worse as the disease is allowed to progress over time. While there is 
potential for symptom reversal, the disease is, by nature, progressive, and focus should 
therefore be placed on the prevention of symptoms rather than on the potential to reverse 
them. While medication and DBS alleviate symptoms and increase the ease with which a 
patient can perform activities of daily living, they do not serve to prevent or delay 
symptoms, only to make it easier for patients to live with the disease. Exercise, on the 
other hand, serves to help patients to maintain their fitness levels and motor function for 
as long as possible, in addition to decreasing the risk of age-related symptoms that may 
accompany PD. 
Further Research 
 Although exercise intervention has been shown to delay the progression of 
symptoms or even reverse symptoms, such as in the case of improvements in the MI 
times of patients involved in the Bergen et al. (2002) study, there is little indication of 
whether or not these gains will last long term, especially if patients cease to exercise. 
Additionally, there seems to be minimal research comparing the symptoms of sedentary 
PD patients who were active before their diagnosis to the symptoms of PD patients who 
have been sedentary their entire life to determine whether or not an active lifestyle pre-
diagnosis will contribute to less severe symptoms as an individual’s disease progresses. 
Additional areas that would benefit from further research include whether or not it is 
possible for exercise intervention to cause a reversal in Hoehn and Yahr stages or 
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UPDRS rating, as well as determining how long the effects of exercise on PD symptoms 
will last if the patient ceases to participate in physical activity. 
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